Regulus Therapeutics Inc(RGLS)

8.16+0.000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- Regulus Therapeutics Inc.5月21日成交额为564.52万美元
  市场透视 · 2025-05-22
  Regulus Therapeutics Inc.5月21日成交额为564.52万美元
- Regulus Therapeutics Inc.5月20日成交额为548.52万美元
  市场透视 · 2025-05-21
  Regulus Therapeutics Inc.5月20日成交额为548.52万美元
- Regulus Therapeutics Inc.5月19日成交额为810.05万美元
  市场透视 · 2025-05-20
  Regulus Therapeutics Inc.5月19日成交额为810.05万美元
- Regulus Therapeutics Inc.2025财年第一财季实现净利润-9.63百万美元，同比减少13.70%
  市场透视 · 2025-05-18
  Regulus Therapeutics Inc.2025财年第一财季实现净利润-9.63百万美元，同比减少13.70%
- Regulus Therapeutics Inc.5月15日成交额为603.85万美元
  市场透视 · 2025-05-16
  Regulus Therapeutics Inc.5月15日成交额为603.85万美元
- Regulus Therapeutics Inc.5月14日成交额为826.53万美元
  市场透视 · 2025-05-15
  Regulus Therapeutics Inc.5月14日成交额为826.53万美元
- Regulus Therapeutics Inc.5月13日成交额为1116.22万美元
  市场透视 · 2025-05-14
  Regulus Therapeutics Inc.5月13日成交额为1116.22万美元
- Regulus Therapeutics Inc.5月8日成交额为546.34万美元
  市场透视 · 2025-05-09
  Regulus Therapeutics Inc.5月8日成交额为546.34万美元
- Regulus Therapeutics(RGLS.US)：2025年Q1财报实现营收0美元，前值为0美元；每股收益为-0.15美元，前值为-0.29美元，预期值为-0.23美元。
  金融界 · 2025-05-09
  Regulus Therapeutics(RGLS.US)：2025年Q1财报实现营收0美元，前值为0美元；每股收益为-0.15美元，前值为-0.29美元，预期值为-0.23美元。
- Regulus Therapeutics Inc.5月7日成交额为764.07万美元
  市场透视 · 2025-05-08
  Regulus Therapeutics Inc.5月7日成交额为764.07万美元
- Regulus Therapeutics Inc.5月6日成交额为742.06万美元
  市场透视 · 2025-05-07
  Regulus Therapeutics Inc.5月6日成交额为742.06万美元
- Regulus Therapeutics Inc.5月2日成交额为2402.04万美元
  市场透视 · 2025-05-03
  Regulus Therapeutics Inc.5月2日成交额为2402.04万美元
- Jones Trading：下调Regulus Therapeutics评级，由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。
  金融界 · 2025-05-01
  Jones Trading：下调Regulus Therapeutics评级，由买入调整至持有评级, 目标价由8.00美元调整至7.00美元。
- 加拿大投资银行集团：下调Regulus Therapeutics(RGLS.US)评级，由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。
  金融界 · 2025-05-01
  加拿大投资银行集团：下调Regulus Therapeutics(RGLS.US)评级，由买入调整至持有评级, 目标价由28.00美元调整至11.00美元。
- Regulus Therapeutics暴涨，诺华拟斥资至多17亿美元收购该公司
  老虎资讯综合 · 2025-04-30
  Regulus Therapeutics暴涨，诺华拟斥资至多17亿美元收购该公司
- Regulus Therapeutics Inc.盘中异动早盘大幅下挫5.01%报3.32美元
  市场透视 · 2025-04-29
  Regulus Therapeutics Inc.盘中异动早盘大幅下挫5.01%报3.32美元
- Regulus Therapeutics Inc.盘中异动快速拉升7.84%
  市场透视 · 2025-04-24
  Regulus Therapeutics Inc.盘中异动快速拉升7.84%
- Regulus Therapeutics Inc.盘中异动早盘股价大涨5.84%报2.46美元
  市场透视 · 2025-04-23
  Regulus Therapeutics Inc.盘中异动早盘股价大涨5.84%报2.46美元
- Regulus Therapeutics Inc.盘中异动早盘股价大涨5.42%
  市场透视 · 2025-04-22
  Regulus Therapeutics Inc.盘中异动早盘股价大涨5.42%
- Regulus Therapeutics Inc.盘中异动早盘急速上涨5.23%
  市场透视 · 2025-04-15
  Regulus Therapeutics Inc.盘中异动早盘急速上涨5.23%
公司概况
公司名称
Regulus Therapeutics Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.regulusrx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Regulus Therapeutics Inc.于2007年9月6日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发针对microRNA的一流药物，以治疗具有重大医疗需求的疾病。
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-06-25
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

分时
5日
日
周
月

数据加载中...

最高

8.16

今开

8.16

量比

0.00

最低

8.16

昨收

8.16

换手率

0.00%

Regulus Therapeutics Inc(RGLS)

公司概况

热议股票